Skip to main content
A

AbClon Inc. — Investor Relations & Filings

Ticker · 174900 ISIN · KR7174900001 KO Manufacturing
Open in API
Filings indexed 252 across all filing types
Latest filing 2025-03-04 Regulatory Filings
Country KR South Korea
Listing KO 174900

About AbClon Inc.

https://www.abclon.com/en/

AbClon Inc. is a clinical-stage company focused on the research and development of antibody-based therapeutics. The company leverages three core proprietary platforms. The CAR-T platform develops personalized cell therapies for cancer patients by engineering a patient's own immune cells to target and destroy cancer cells, with a focus on blood cancers. The NEST (Novel Epitope Screening Technology) platform is designed to discover antibodies that target unique, previously unaddressed sites on disease proteins, enabling novel therapeutic effects. The AffiMab platform facilitates the development of bispecific antibodies that can simultaneously engage two different disease targets, aiming to maximize therapeutic efficacy in refractory diseases.

Recent filings

Filing Released Lang Actions
투자판단관련주요경영사항 (CART 세포치료제 `AT101` 기술이전 계약 체결)
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from a Korean company (AbClon) regarding a technology transfer agreement for a CAR-T cell therapy (AT101). This type of filing, which details a significant business contract, licensing, or partnership, falls under the category of M&A Activity (TAR) in the provided schema, as it relates to the commercialization and licensing of intellectual property assets.
2025-03-04 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 1% confidence The document is a regulatory filing from a Korean company (AbClon) regarding a significant change in financial structure (30% or more change in revenue or profit/loss). This is a standard disclosure requirement for listed companies in Korea (KRX) to report preliminary financial results or significant fluctuations before the final audit report is finalized. Since it provides key financial highlights and performance metrics rather than a full annual report or a simple announcement of a report's availability, it falls under the 'Earnings Release' category. FY 2024
2025-01-31 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 1% confidence The document is a short regulatory announcement from AbClon regarding the setting of a record date and shareholder register closure for their upcoming Annual General Meeting (AGM). It is a brief notification (423 characters) rather than the full AGM presentation or proxy statement itself. Since it serves as a formal regulatory notice regarding meeting preparation, it falls under the general regulatory filing category.
2024-12-13 Korean
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing titled '증권 발행결과' (Securities Issuance Result) regarding a third-party capital increase (유상증자) through convertible preferred shares. It details the number of shares issued, the total amount, and the payment date. This falls under the category of share issuance and capital changes.
2024-12-13 Korean
증권발행결과(자율공시)
Capital/Financing Update Classification · 1% confidence The document is a formal announcement regarding the 'Result of Securities Issuance' (증권 발행결과) for a private placement of convertible bonds (전환사채). It details the issuance amount, payment date, and confirms the completion of the financing activity. This falls under the category of company fundraising and financing updates.
2024-12-13 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Korean Financial Services Commission and the Korea Exchange. It specifically details a 'Decision on Paid-in Capital Increase' (유상증자결정) and provides a 'Correction Report' (정정신고) regarding the terms of a third-party allocation of shares, including changes to issuance amounts, conversion prices, and investor details. This falls under the category of announcements regarding capital changes and share issuance.
2024-11-28 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.